Results 41 to 50 of about 64,174 (311)

The potential role of benfotiamine in the treatment of diabetic cardiac autonomic neuropathy

Mìžnarodnij Endokrinologìčnij Žurnal, 2020
Background. Cardiac autonomic neuropathy is a serious complication of diabetes mellitus that is strongly associated with approximately five-fold increased risk of cardiovascular mortality.
V.A. Serhiyenko, V.B. Segin, L.M. Serhiyenko, A.A. Serhiyenko   +3 more
doaj   +1 more source

Significant correlation between taste dysfunction and HbA1C level and blood sugar fasting level in type 2 diabetes mellitus patients in at a tertiary care center in north India

Diabetes Epidemiology and Management, 2022
Type 2 diabetes mellitus (T2DM) effect quality of life very much and causes various complications. Diabetic autonomic neuropathy (DAN) is one of the common complications in diabetes.
Jitendra Singh Kushwaha, Vishal Kumar Gupta, Archana Singh, Richa Giri   +3 more
doaj   +1 more source

Prevalence of Cardiovascular Autonomic Neuropathy among Type 2 Diabetic Patients in Erbil City

Advanced Medical Journal
Background and objectives: Type 2 diabetes affects over 500 million people worldwide. Damage to the autonomic nerve fibers that innervate the heart and blood vessels is known as cardiac-autonomic-neuropathy.
Wshyar Sadraldeen Haris, Yousif Baha’addin Ahmed   +1 more
doaj   +1 more source

Cardiac autonomic neuropathy

Revista de la Sociedad Argentina de Diabetes, 2020
Cardiac autonomic neuropathy (CAP) is a frequent and early-onset microvascular complication of diabetes mellitus (DM) that implies an increased cardiovascular risk, with increased mortality.
Raquel Urdaneta
doaj   +1 more source

Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients. [PDF]

, 2007
This study investigated whether nondipping (defined as a day–night change in blood pressure (BP)
Frajese, G, Maiello, MR, Mandica, S, Morganti, R, Spallone, V   +4 more
core   +1 more source

Cardiovascular Autonomic Neuropathyin Chronic Kidney Diseases

Journal of Nepal Medical Association, 2010
INTRODUCTION: This study was conducted to explore cardiovascular autonomic neuropathy and its pattern in chronic kidney disease patients. METHODS: Autonomic function using five standard tests was examined in 20 diabetic patients with CKD, 20 age ...
L Thapa, P Karki, SK Sharma, BK Bajaj
doaj   +1 more source

Diabetes in Sub Saharan Africa 1999-2011: Epidemiology and Public Health Implications. A Systematic Review. [PDF]

, 2011
Diabetes prevalence is increasing globally, and Sub-Saharan Africa is no exception. With diverse health challenges, health authorities in Sub-Saharan Africa and international donors need robust data on the epidemiology and impact of diabetes in order to ...
Hall, Victoria, Henriksen, Ole, Lohse, Nicolai, Thomsen, Reimar W   +3 more
core   +2 more sources

Insights Into the Antigenic Repertoire of Unclassified Synaptic Antibodies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We sought to characterize the sixth most common finding in our neuroimmunological laboratory practice (tissue assay‐observed unclassified neural antibodies [UNAs]), combining protein microarray and phage immunoprecipitation sequencing (PhIP‐Seq). Methods Patient specimens (258; 133 serums; 125 CSF) meeting UNA criteria were profiled;
Michael Gilligan, John R. Mills, Paulina Vargas, Naveen K. Paramasivan, Connie E. Lesnick, Eati Basal, Surendra Dasari, James P. Fryer, Shannon R. Hinson, Joseph Laporta, Amy Espinal, Dennis Fitzgerald, Carolina Garcia, Anna E. Morenkova, Paola Pergami, Anna Shah, Andrew Knight, Reghann LaFrance Corey, Vanda A. Lennon, Anastasia Zekeridou, Sean J. Pittock, Divyanshu Dubey, Andrew McKeon   +22 more
wiley   +1 more source

Pathophysiological and clinical aspects of the circadian rhythm of arterial stiffness in diabetes mellitus: A minireview

Endocrine Regulations, 2022
Several cross-sectional trials have revealed increased arterial stiffness connected with the cardiac autonomic neuropathy in types 2 and 1 diabetic patients.
Serhiyenko Victoria A., Serhiyenko Ludmila M., Sehin Volodymyr B., Serhiyenko Alexandr A.   +3 more
doaj   +1 more source

The Case of a 37‐Year‐Old Woman Presenting With Subacute Weakness and Paresthesias

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Acute intermittent porphyria (AIP) is a rare metabolic disorder that may present with subacute neuropathy and systemic symptoms, often leading to diagnostic delay. We report a 37‐year‐old woman with eight weeks of progressive bilateral upper extremity weakness and paresthesias, followed by lower extremity involvement and falls, in the setting ...
Peter Pacut, Joy Cannon, Neel Dixit, Qihua Fan   +3 more
wiley   +1 more source